Overview

Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
Comparing the efficacy and safety of a gel formulation containing a combination of clindamycin phosphate (equivalent to 1% clindamycin) and benzoyl peroxide (5%) once daily with a gel containing 0.1% adapalene once daily in the treatment of acne vulgaris of mild to moderate severity.
Phase:
Phase 4
Details
Lead Sponsor:
Stiefel, a GSK Company
Collaborator:
GlaxoSmithKline
Treatments:
Adapalene